Your Cart ( 1 Item )

• Safety and Efficacy of TGF-β1/COX-2 Silencing Therapeutic in Adults With Cutaneous Squamous Cell Carcinoma In Situ
  May 2022 | Volume 21 | Issue 5 | Original Article | 472 | Copyright © May 2022
  Mark Nestor MD PhD^a,b, Brian Berman MD PhD^a,b, Patrick Lu PhD^c, Michael Molyneaux MD^c
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs